VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2021 | Unmet needs in Hodgkin lymphoma

Julia Driessen, MBBS, University of Amsterdam, Amsterdam, The Netherlands, comments on the improving cure rates for patients with Hodgkin lymphoma, highlighting the need for improved treatment regimens for older patients and the potential role of brentuximab vedotin and PD-1 inhibitors, as well as the need to improve the balance between efficacy and toxicity. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter